ClinicalTrials.govpublic full text
Study to Assess Adverse Events and Change in Disease Activity in Previously Treated Adult Participants Receiving Intravenous (IV) ABBV-400 With Unresectable Metastatic Colorectal Cancer in Combination With IV Fluorouracil, Folinic Acid, and Bevacizumab
unresectable metastatic colorectal cancer, abbv-400, fluorouracil, folinic acid, bevacizumab, cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 979082
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.